Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19

Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not uncommonly encountered in patients with COVID-19. Increasingly, all evidence currently available hints that both new-onset hyperglycemia without diabetes and new-onset diabetes in COVID-19 is associated with a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Awadhesh Kumar, Singh, Ritu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445123/
https://www.ncbi.nlm.nih.gov/pubmed/32853686
http://dx.doi.org/10.1016/j.diabres.2020.108382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445123/
https://www.ncbi.nlm.nih.gov/pubmed/32853686
http://dx.doi.org/10.1016/j.diabres.2020.108382

Ejemplares similares